Using placenta-derived stem cells for novel medical therapies
Using placenta-derived stem cells for novel medical therapies
…
Robert Hariri at TEDMED 2011
The Cellular Therapeutics CEO talks about his research in using placenta-derived stem cells as novel therapy for Crohn’s disease, and to create new “organoids” for research and transplants.
…
Past research has suggested that human placentas are a rich source of stem cells that may prove useful in treating leukemia, heart disease and multiple sclerosis.
In this TEDMED 2011 talk, Robert Hariri, MD, PhD, chief executive officer of Cellular Therapeutics Division at Celgene, discusses the challenges and potential benefits of transforming stem cells harvested from the placenta into novel medical therapies for a variety of conditions.
Via Medgadget
By Lia Steakley
Stanford University Medical Center
###
* Stanford University Medical Center integrates research, medical education and patient care at its three institutions – Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital.
** The above story is adapted from materials provided by Stanford University School of Medicine
________________________________________________________________